81
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The challenge of flavonoid/cyclodextrin complexation in a complex matrix of the quercetin, luteolin, and 3-O-methylquercetin

, , , , , & ORCID Icon show all
Pages 625-634 | Received 29 Apr 2022, Accepted 01 Jul 2022, Published online: 11 Jul 2022

References

  • Agrawal PK, Agrawal C, Blunden G. 2020. Quercetin: antiviral significance and possible COVID-19 integrative considerations. Nat Prod Commun. 15:1–10.
  • Arora D, Saneja A, Jaglan S. 2018. Cyclodextrin-based carriers for delivery of dietary phytochemicals. In: Fourmentin S, Crini G, Lichtfouse E, editors. Cyclodextrin applications in medicine, food, environment and liquid crystals. Berlin: Springer International Publishing AG; p. 1–17.
  • Bettega JMR, Teixeira HF, Bassani VL, Barardi CRM, Simões CMO. 2004. Evaluation of the antiherpetic activity of standardized extracts of Achyrocline satureioides. Phytother Res. 18(10):819–823.
  • Bidone J, Bica VC, Petrovick PR, Simões CMO, Koester LS, Bassani VL, Teixeira HF. 2014. Simultaneous quantification of flavonoids from Achyrocline satureioides by a polar-reversed phase LC method-application to skin permeation/retention studies. Pharmazie. 69(1):5–9.
  • Borghetti GS, Lula IS, Sinisterra RD, Bassani VL. 2009. Quercetin/β-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture. AAPS PharmSciTech. 10(1):235–242.
  • Brand-Williams W, Cuvelier ME, Berset C. 1995. Use of a free radical method to evaluate antioxidant activity. LWT. 28(1):25–30.
  • Brewster ME, Loftsson T. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 59(7):645–666.
  • Calvo D, Cariddi LN, Grosso M, Demo MS, Maldonado AM. 2006. Achyrocline satureioides (LAM.) DC (Marcela): antimicrobial activity on Staphylococcus spp. and immunomodulating effects on human lymphocytes. Rev Latinoam Microbiol. 48(3–4):247–255.
  • Carini JP, Klamt F, Bassani VL. 2014. Flavonoids from Achyrocline satureioides: promising biomolecules for anticancer therapy. RSC Adv. 4(7):3131–3144.
  • Cherukuvada S, Nangia A. 2014. Eutectics as improved pharmaceutical materials: design, properties and characterization. Chem Commun. 50(8):906–923.
  • Cosentino M, Bombelli R, Carcano E, Luini A, Marino F, Crema F, Dajas F, Lecchini S. 2008. Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes. J Ethnopharmacol. 116(3):501–507.
  • Cova FC, Milne BF, Pais AACC. 2019. Host flexibility and space filling in supramolecular complexation of cyclodextrins: a free-energy-oriented approach. Carbohydr Polym. 205:42–54.
  • Daina A, Michielin O, Zoete V. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 7:1–13.
  • D’Aria F, Serri C, Niccoli M, Mayol L, Quagliariello V, Iaffaioli RV, Biondi M, Giancola C. 2017. Host–guest inclusion complex of quercetin and hydroxypropyl-β-cyclodextrin. J Therm Anal Calorim. 130(1):451–456.
  • Das SS, Singh NP, Agrawal T, Gupta P, Tiwari SN, Singh NB. 2009. Studies of solidification behavior and molecular interaction in benzoic acid-o-chloro benzoic acid eutectic system. Mol Cryst Liq Cryst. 501(1):107–124.
  • De Souza KCB, Bassani VL, Schapoval EES. 2007. Influence of excipients and technological process on anti-inflammatory activity of quercetin and Achyrocline satureioides (Lam.) D.C. extracts by oral route. Phytomedicine. 14(2–3):102–108.
  • Doneda E, Bianchi SE, Pittol V, Kreutz T, Scholl JN, Ibañez IL, Bracalente C, Durán H, Figueiró F, Klamt F, et al. 2021. 3-O‑Methylquercetin from Achyrocline satureioides—cytotoxic activity against A375‑derived human melanoma cell lines and its incorporation into cyclodextrins‑hydrogels for topical administration. Drug Deliv Transl Res. 11(5):2151–2168.
  • Dong L, Liu M, Chen A, Wang Y, Sun D. 2013. Solubilities of quercetin in three β-cyclodextrin derivative solutions at different temperatures. J Mol Liq. 177:204–208.
  • Francisco V, Figueirinha A, Costa G, Liberal J, Lopes MC, García-Rodríguez C, Geraldes CF, Cruz MT, Batista MT. 2014. Chemical characterization and anti-inflammatory activity of luteolin glycosides isolated from lemongrass. J Funct Foods. 10:436–443.
  • Gajare P, Patil C, Kalyane N, Pore Y. 2009. Effect of hydrophilic polymers on Pioglitazone complexation with hydroxypropyl-β-cyclodextrin. Dig J Nanomater Bios. 4(4):891–897.
  • Goltz C, Ávila S, Barbieri JB, Igarashi-Mafra L, Mafra MR. 2018. Ultrasound-assisted extraction of phenolic compounds from Macela (Achyrocline satureioides) extracts. Ind Crops Prod. 115:227–234.
  • Gupta RK, Singh RA. 2004. Thermochemical and microstructural studies on binary organic eutectics and complexes. J Cryst Growth. 267(1–2):340–347.
  • Higuchi T, Connors KA. 1965. Phase solubility techniques. J Am Chem Soc. 4:117–212.
  • Huang Z-R, Hung C-F, Lin Y-K, Fang J-Y. 2008. Fang, In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm. 364(1):36–44.
  • Ilyich TV, Lapshina EA, Maskevich AA, Veiko AG, Lavysh AV, Palecz B, Stępniak A, Buko VU, Zavodnik IB. 2020. Inclusion complexes of quercetin with β-cyclodextrins: ultraviolet and infrared spectroscopy and quantum chemical modeling. Biophysics. 65(3):381–389.
  • Jambhekar SS, Breen P. 2016. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex Drug. Drug Discov Today. 21(2):356–362.
  • Jansook P, Ogawa N, Loftsson T. 2018. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. Int J Pharm. 535(1–2):272–284.
  • Jullian C, Cifuentes C, Alfaro M, Miranda S, Barriga G, Olea-Azar C. 2010. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized β-cyclodextrin. Bioorg Med Chem. 18(14):5025–5031.
  • Jullian C, Moyano L, Yañez C, Olea-Azar C. 2007. Complexation of quercetin with three kinds of cyclodextrins: an antioxidant study. Spectrochim Acta A Mol Biomol Spectrosc. 67(1):230–234.
  • Kalogeropoulos N, Konteles S, Mourtzinos I, Troullidou E, Chiou A, Karathanos VT. 2009. Encapsulation of complex extracts in β-cyclodextrin: an application to propolis ethanolic extract. J Microencapsul. 26(7):603–613.
  • Kfoury M, Auezova L, Greige-Gerges H, Ruellan S, Fourmentin S. 2014. Cyclodextrin, an efficient tool for trans-anethole encapsulation: chromatographic, spectroscopic, thermal and structural studies. Food Chem. 164:454–461.
  • Kumar S, Bhargava D, Thakkar A, Arora S. 2013. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review. Crit Rev Ther Drug Carrier Syst. 30(3):217–256.
  • Kumar S, Pandey AK. 2013. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013:1–16.
  • Liu B, Li W, Zhao J, Liu Y, Zhu X, Liang G. 2013. Physicochemical characterization of the supramolecular structure of luteolin/cyclodextrin inclusion complex. Food Chem. 141(2):900–906.
  • Liu M, Dong L, Chen A, Zheng Y, Sun D, Wang X, Wang B. 2013. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity. Spectrochim Acta A Mol Biomol Spectrosc. 115:854–860.
  • Loftsson T, Brewster M. 1996. Pharmaceutical applications of cyclodextrins. Drug solubilization and stabilization. J Pharm Sci. 85(10):1017–1025.
  • Loftsson T, Duchêne D. 2007. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 329(1–2):1–11.
  • Loftsson T, Hreinsdóttir D, Másson M. 2005. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 302(1–2):18–28.
  • Loftsson T, Hreinsdóttir D, Másson M. 2007. The complexation efficiency. J Incl Phenom Macrocycl Chem. 57(1–4):545–552.
  • Lucas-Abellán C, Fortea I, Gabaldón JA, Núñez-Delicado E. 2008. Encapsulation of quercetin and myricetin in cyclodextrins at acidic Ph. J Agric Food Chem. 56(1):255–259.
  • Nikolic IL, Savic IM, Popsavin MM, Rakic SJ, Mihajilov-Krstev TM, Ristic IS, Eric SP, Savic-Gajic IM. 2018. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin. J Pharm Pharmacol. 70(11):1485–1493.
  • Olga G, Styliani C, Ioannis RG. 2015. Coencapsulation of ferulic and gallic acid in HP-β-cyclodextrin. Food Chem. 185:33–40.
  • Oliveira SGD, De Moura FRR, Demarco FF, Nascente PS, Del Pino FAB, Lund RG. 2012. An ethnomedicinal survey on phytotherapy with professionals and patients from Basic Care Units in the Brazilian Unified Health System. J Ethnopharmacol. 140(2):428–437.
  • Pittol V, Ortega GG, Doneda E, Bianchi SE, Santos MC, Koetz M, Henriques AT, Bassani VL. 2020. Box-Behnken design for extraction optimization followed by high performance countercurrent chromatography: production of a flavonoid-enriched fraction from Achyrocline satureioides. Planta Med. 86(2):151–159.
  • Polydoro M, de Souza KCB, Andrades ME, Da Silva EG, Bonatto F, Heydrich J, Dal-Pizzol F, Schapoval EES, Bassani VL, Moreira JCF. 2004. Antioxidant, a pro-oxidant and cytotoxic effects of Achyrocline satureioides extracts. Life Sci. 74(23):2815–2826.
  • Pralhad T, Rajendrakumar K. 2004. Study of freeze-dried quercetin–cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal. 34(2):333–339.
  • Reddy CK, Jung ES, Son SY, Lee CH. 2020. Inclusion complexation of catechins-rich green tea extract by β-cyclodextrin: preparation, physicochemical, thermal, and antioxidant properties. LWT. 131:109723–109710.
  • Retta D, Dellacassa E, Villamil J, Suárez SA, Bandoni AL. 2012. Marcela, a promising medicinal and aromatic plant from Latin America: a review. Ind Crops Prod. 38:27–38.
  • Rothwell JA, Day AJ, Morgan MRA. 2005. Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem. 53(11):4355–4360.
  • Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo GL. 2020. Roles of flavonoids against coronavirus infection. Chem-Biol Interact. 328:1–13.
  • Sabini MC, Escobar FM, Tonn CE, Zanon SM, Contigiani MS, Sabini LI. 2012. Evaluation of antiviral activity of aqueous extracts from Achyrocline satureioides against Western equine encephalitis virus. Nat Prod Res. 26(5):405–415.
  • Salgueiro AC, Folmer V, da Rosa HS, Costa MT, Boligon AA, Paula FR, Roos DH, Puntel GO. 2016. In vitro and in silico antioxidant and toxicological activities of Achyrocline satureioides. J Ethnopharmacol. 194(194):6–14.
  • Saokham P, Muankaew C, Jansook P, Loftsson T. 2018. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 23(5):1161–1176.
  • Savic IM, Jocic E, Nikolic VD, Popsavin MM, Rakic SJ, Savic-Gajic IM. 2019. The effect of complexation with cyclodextrins on the antioxidant and antimicrobial activity of ellagic acid. Pharm Dev Technol. 24(4):410–418.
  • Savic IM, Nikolic VD, Savic-Gajic I, Nikolic LB, Radovanovic BC, Mladenovic JD. 2015. Investigation of properties and structural characterization of the quercetin inclusion complex with (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 82(3–4):383–394.
  • Savic IM, Savic-Gajic IM, Nikolic VD, Nikolic LB, Radovanovic BC, Milenkovic-Andjelkovic A. 2016. Enhencemnet of solubility and photostability of rutin by complexation with β-cyclodextrin and (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 86(1–2):33–43.
  • Savic-Gajic I, Savic IM, Nikolic VD, Nikolic LB, Popsavin MM, Kapor AJ. 2016. Study of the solubility, photostability and structure of inclusion complexes of carvedilol with β-cyclodextrin and (2-hydroxypropyl)-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 86(1–2):7–17.
  • Schwingel L, Fasolo D, Holzschuh M, Lula I, Sinisterra R, Koester L, Teixeira H, Bassani VL. 2008. Association of 3-O-methylquercetin with β-cyclodextrin: complex preparation, characterization and ex vivo skin permeation studies. J Incl Phenom Macrocycl Chem. 62(1–2):149–159.
  • Sharma N, Baldi A. 2016. Exploring versatile applications of cyclodextrins: an overview. Drug Deliv. 23(3):729–747.
  • Simões CMO, Schenkel EP, Bauer L, Langeloh A. 1988. Pharmacological investigations on Achyrocline satureioides (Lam.) D.C. compositae. J. Ethnopharmacol. 22(3):281–293.
  • Siqueira IR, Simões CMO, Bassani VL. 2021. Achyrocline satureioides (Lam.) D.C. as a potential approach for management of viral respiratory infections. Phytotherapy Res. 35(1):3–3.
  • Solnier J, Fladerer JP. 2021. Flavonoids: a complementary approach to conventional therapy of COVID-19? Phytochem Rev. 20(4):773–795.
  • Souza PO, Bianchi SE, Figueiro F, Heimfarth L, Moresco KS, Gonçalves RM, Hoppe JB, Klein CP, Salbego CG, Gelain DP, et al. 2018. Anticancer activity of flavonoids isolated from Achyrocline satureioides in gliomas cell lines. Toxicol In Vitro. 51:23–33.
  • Suvarna V, Gujar P, Murahari M. 2017. Complexation of phytochemicals with cyclodextrin derivatives – an insight. Biomed Pharmacother. 88:1122–1144.
  • Vertzoni M, Kartezini T, Reppas C, Archontaki H, Valsami G. 2006. Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems. Int J Pharm. 309(1-2):115–122.
  • Yang B, Yang LJ, Lin J, Chen Y, Liu Y. 2009. Binding behaviors of scutellarin with α-, β-, γ-cyclodextrins and their derivatives. J Incl Phenom Macrocycl Chem. 64(1–2):149–155.
  • Yatsu FKJ, Koester LS, Lula I, Passos JJ, Sinisterra R, Bassani VL. 2013. Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction. Carbohydr Polym. 98(1):726–735.
  • Yu R, Chen L, Lan R, Shen R, Li P. 2020. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int J Antimicrob Agents. 56:1–6.
  • Zheng Y, Haworth IS, Zuo Z, Chow MSS, Chow AHL. 2005. Physicochemical and structural characterization of quercetin-β-cyclodextrin complexes. J Pharm Sci. 94(5):1079–1089.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.